Oral ciprofloxacin is ineffective in culture-negative peritonitis
Trakarnvanich, T.; Thitiarchakul, S.; Kurathong, P.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 21(2): 199-200
2001
ISSN/ISBN: 0896-8608 PMID: 11330568 Document Number: 529884
Document emailed within 1 workday
Related Documents
Boer, W.H.; Vos, P.F.; Fieren, M.W.J.A. 2003: Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 33-38Sheridan, J.E.; White, J.; Fairchild, T.J. 1992: Ineffective staff, ineffective supervision, or ineffective administration? Why some nursing homes fail to provide adequate care Gerontologist 32(3): 334-341
Demoulin, N.; Goffin, E. 2009: Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(5): 548-553
Chou, C.-Y.; Kao, M.-T.; Kuo, H.-L.; Liu, J.S.; Liu, Y.-L.; Huang, C.-C. 2006: Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(5): 607-608
Chmielewski, M.; Lichodziejewska-Niemierko, M.; Liberek, T.; Naumiuk, L.; Samet, A.; Rutkowski, B. 2004: Ciprofloxacin as adjunctive agent in treating cryptococcal peritonitis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(5): 487-488
Speciale, A.; Blandino, G.; Pellegrino, M.B.; Borghi, P.; Caccamo, F. 1986: In vitro activity of ciprofloxacin against aminoglycoside-sensitive and -resistant gram-negative rods Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(3): 196-199
Rasi, A.; Tajziehchi, L.; Savabi-Nasab, S. 2008: Oral erythromycin is ineffective in the treatment of pityriasis rosea Journal of Drugs in Dermatology: Jdd 7(1): 35-38
García del Busto Remón, A.; Pardo, F.; Moreno, R.; Galiano, J.V. 1996: Gram-negative bacilli isolated in a general hospital: high rate of ciprofloxacin resistance Enfermedades Infecciosas y Microbiologia Clinica 14(4): 276-277
Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J. 2003: Comparative bioavailability of two oral formulations of ciprofloxacin Proceedings of the Western Pharmacology Society 46: 134-135
Yangco, B.G.; Kenyon, V.S.; Halkias, K.D.; Bogel, J.A.; Toney, J.F.; Chmel, H. 1989: Oral ciprofloxacin treatment of infections in geriatric patients Clinical Therapeutics 11(4): 503-510
Mounier, M.; Adenis, J.P.; Denis, F. 1988: Intraocular penetration of ciprofloxacin after infusion and oral administration Pathologie-Biologie 36(5 Part 2): 724-727
Parras, F.; Torroba, L.; Buzón, L.; Martínez-Beltrán, J.; Loza, E.; Baquero, F. 1989: Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients Enfermedades Infecciosas y Microbiologia Clinica 7(5): 261-265
Barriere, S.L. 1987: Economic impact of oral ciprofloxacin. a pharmacist's perspective American Journal of Medicine 82(4a): 387-390
Bergan, T.; Thorsteinsson, S.B.; Solberg, R.; Bjornskau, L.; Kolstad, I.M.; Johnsen, S. 1987: Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses American Journal of Medicine 82(4a): 97-102
Saengsuwan, P.; Jaruratanasirikul, S.; Jullangkoon, M.; Aeinlang, N. 2010: Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia Journal of the Medical Association of Thailand 93(7): 784-788
Szeto, C.-C.; Chow, K.-M. 2007: Gram-negative peritonitis--the Achilles heel of peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(Suppl 2): S267-S271
Sudo, R.T.; Melo, P.A.; Suarez-Kurtz, G. 1990: Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects Brazilian Journal of Medical and Biological Research 23(12): 1315-1321
Caruso, E.; Castro, J.M.; Chamoles, N.; Galimberti, R.; Jorge, L.; Rohwedder, R. 1989: Penetration of ciprofloxacin into human lung tissue after oral and I.v. dosing Journal of ChemoTherapy 1(4 Suppl): 549-551
Melita-Manoli, H.; Vatopoulos, A.; Toutouza, M.; Drivas, G.; Katirtzoglou, A. 1993: The significance of slime-producing coagulase-negative staphylococci in CAPD peritonitis Clinical Nephrology 39(2): 111
Esposito, S.; Galante, D.; Barba, D.; D'Errico, G.; Mazzone, A.; Montanaro, S. 1987: Ciprofloxacin concentrations in human fluids and tissues following a single oral dose International Journal of Clinical Pharmacology Research 7(3): 181-186